Featured Corporate Partner of the Cystic Fibrosis Foundation

Just thought I'd share this nice little story about Genetech that was featured on the CFF Website. The more sponsors that we can get to do stuff like Genetech is doing, the faster we will reach our cure. If you or someone you know works for a company who might be interested in partnering with the CFF during this exciting time when we are so close to a cure, please don't hesitate to contact me or anyone at your local CFF office.

Genentech: Making CF History

Genentech has been a generous corporate partner of the Cystic Fibrosis Foundation for more than a decade, and today, its employees are more committed than ever to making CF a thing of the past.

“Participating is important to Genentech because we know that the money raised goes back to funding the research we’re so passionate about,” says Sheri Morin, senior director of sales and marketing. “It only makes sense for us to be involved!”

Genentech is both a national sponsor of Great Strides and a supporter of local walks in Northern California, where the biotech company is headquartered. During Great Strides season, Genentech encourages its 11,000 employees to join a team or make a donation.

Caring for the CF Community

Team Genentech at the Great Strides walk in San Francisco, California.

In addition to their passionate support of Great Strides, Genentech employees contribute to a variety of regional and local events year-round to raise funds for CF research and medical programs.

Genentech is also committed to ensuring all people living with CF and their families have access to the information and treatment support they need to stay as healthy as possible.

Many of the educational resources the CF Foundation provides to the community are made possible with significant support from Genentech.

For example, in 2010, with an unrestricted educational grant from Genentech, the Foundation established a CF education webcast series to bring the cystic fibrosis community together in a virtual forum to learn from CF experts nationwide.

In addition, the company supports research that aims to identify new ways that doctors can help patients stick to their prescribed treatment regimens.

In 2009, Genetech contributed a total of nearly $700,000 to the support the search for a cure.

“Genentech is a company that has long demonstrated it cares about the CF community,” says C. Richard Mattingly, executive vice president and chief operating officer of the CF Foundation. “We are so grateful for everything they do to support better health and a brighter future for people with cystic fibrosis.”